Sun Pharma gains 3% on possible Intas acquisition

The company is in early talks to acquire Intas Pharma, says report.

Shares of Sun Pharma are currently trading 2.53% higher at Rs. 788.50 on BSE on media reports about the company is in early talks to acquire Intas Pharma. 

The deal size is reportedly estimated at Rs. 15,000 crore (US$ 3.2 billion). 

The scrip opened higher at Rs. 771 as against its previous close of Rs. 764.15. It hit a high and a low of Rs. 790 and Rs. 771 respectively. So far, 1.5 lk share have changed hands on BSE.